(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug

SEOUL, Nov. 5 (Yonhap) -- SK Biopharmaceuticals Co., a biopharmaceutical arm of ...
Read the full story at Yonhap EnglishOpen in the live monitor

SEOUL, Nov. 5 (Yonhap) -- SK Biopharmaceuticals Co., a biopharmaceutical arm of ...
Read the full story at Yonhap EnglishOpen in the live monitor
No group discusses this yet. Start a discussion group and attach this story.